Loading provider…
Loading provider…
Medical Oncology Physician in Montvale, NJ
NPI: 1336383637Primary Practice Location
VALLEY HOSPITAL
4 Valley Health Plz, Paramus, NJ
Primary Employer
Msk Bergen
mskcc.org
HQ Phone
Get MD Ping's Phone NumberMobile
Get MD Ping's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
Nanjing Medical University
Medical School
Until 1985
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 219 | 1,087 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 130 | 321 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 94 | 94 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 54 | 71 |
Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer.
Authors: David Jones, Zsofia Stadler, Yelena Janjigian, Monika Laszkowska, Mark Schattner, Jia Li, Daniela Molena, Geoffrey Ku, Laura Tang, Steven Maron, David Ilson, Hans Gerdes, Daniel Coit, Elizabeth Won, Steven Maron, Smita Sihag, Vivian Strong
Journal: J Natl Cancer Inst
Authors: Maria Castano, Philip Paty, Diana Roth O'Brien, Iris Wei, Paul Romesser, Julio Garcia-Aguilar, Jesse Smith, Christopher Crane, Georgios Karagkounis, Leonard Saltz, Carla Hajj, Martin Weiser, Marina Shcherba, Garrett Nash, Emmanouil Pappou
Journal: J Clin Med
Publication Date: 2024-04-09
Authors: Maryann Kwa, Yelena Novik, James Speyer, Komal Jhaveri, Marleen Meyers
Journal: Breast Cancer Res Treat
Publication Date: 2017-11-09
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, DRUG: Sapanisertib
Lead Sponsor: NYU Langone Health
Collaborators: AstraZeneca
Intervention / Treatment: DRUG: Irinotecan, DRUG: AZD1775